NovelStem International Reports Strong Q2 2025 Turnaround Amid Ongoing Financial Challenges

Company Overview: NovelStem International Corp. (PINK: NSTM) is a Florida-based holding company focusing on biotechnology and media sectors. The company's primary assets include significant equity interests in NewStem Ltd and previously, NetCo Partners.

Financial Highlights (Q2 2025):

• Net income for the six months ended June 30, 2025, was approximately $2.55 million, compared to a net loss of $606,000 in the same period in 2024.
• Administrative fee income for Q2 2025 was $0, a significant drop from $6,000 in Q2 2024.
• General and administrative expenses decreased from $327,336 in six months 2024 to $158,537 in six months 2025.
• Gain on disposal of investments totaled $1.17 million, attributed to the sale of NetCo to reduce outstanding liabilities.
• Current assets fell from approximately $32,000 in December 2024 to about $15,292 in June 2025.
• Current liabilities decreased significantly from $5.3 million to $1.99 million, largely due to settlements related to litigation funding.

Positive Aspects:

• Substantial net income turnaround driven by strategic asset monetization.
• Reduction in operating expenses indicates improved cost management.
• Successful settlement of liabilities related to litigation funding alleviates immediate financial pressure.

Negative Aspects:

• Complete impairment of investment in NewStem, reflecting the challenges in monetizing its assets.
• Continued reliance on financing, indicating ongoing liquidity concerns; current cash is down to approximately $1,106.
• Majority of operational revenue (administrative fee income) is non-existent, indicating vulnerabilities in generating consistent revenue streams.

Conclusion: NovelStem International Corp. has shown considerable financial improvements in Q2 2025, particularly via net income growth and a decrease in overall liabilities. However, the company's fundamental challenges, particularly concerning revenue generation and dependency on external funding, highlight an unstable business environment going forward. Management's efforts to monetize NewStem's technology and ongoing support from shareholders will be crucial for future success.